Heron Therapeutics' (HRTX) Price Target Raised to $54 at BofA/Merrill Lynch

Go back to Heron Therapeutics' (HRTX) Price Target Raised to $54 at BofA/Merrill Lynch
HERON THERAPEUTICS (NASDAQ: HRTX) Delayed: 0.43 -0.02 (4.44%)
Previous Close $0.45    52 Week High $31.32 
Open $0.45    52 Week Low $13.95 
Day High $0.45    P/E N/A 
Day Low $0.42    EPS $-3.29 
Volume 1,568,049